15-07-2025
The new technique that has ‘transformed' breast cancer treatment
A new, more targeted radiotherapy treatment for low-risk breast cancer has been adopted by the NHS, aiming to reduce debilitating side effects.
The Import Low trial, involving over 2,000 women, demonstrated that limiting radiation to the tumour area is as effective as treating the whole breast in preventing cancer recurrence over a decade.
Patients undergoing this partial-breast radiotherapy experienced significantly fewer side effects and changes in breast appearance compared to those receiving whole-breast treatment.
Researchers from The Institute of Cancer Research and the University of Cambridge led the study, which has "transformed" the approach to early breast cancer treatment.
This new method is now integrated into NHS treatment guidelines and informs international practices, with over 9,000 women in the UK potentially benefiting.
